Mineralocorticoid receptor (MR) antagonist eplerenone and MR modulator balcinrenone prevent renal extracellular matrix remodeling and inflammation via the MR/proteoglycan/TLR4 pathway
- Palacios-Ramirez, R.
- Soulié, M.
- Fernandez-Celis, A.
- Nakamura, T.
- Boujardine, N.
- Bonnard, B.
- Bamberg, K.
- Lopez-Andres, N.
- Jaisser, F.
ISSN: 1470-8736
Year of publication: 2024
Volume: 138
Issue: 16
Pages: 1025-1038
Type: Article